Patents by Inventor Mylene Lesenechal

Mylene Lesenechal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies directed against hepatitis B viruses
    Patent number: 7785586
    Abstract: The present invention relates to a monoclonal antibody capable of binding to a wild-type HBsAg antigen and to at least one, preferably at least two and advantageously more than two, mutant forms of the HBsAg antigen, said monoclonal antibody binding to a peptide sequence consisting of at least 6 contiguous amino acids in the 199-208 region of the HBsAg antigen, and advantageously binding to the peptide sequence constituted by the 199-208 region of the HBsAg antigen.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: August 31, 2010
    Assignee: Biomerieux SA
    Inventors: Colette Jolivet-Reynaud, Mylene Lesenechal, Nicole Battail-Poirot, Laurence Becquart
  • Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease
    Patent number: 6933110
    Abstract: The nucleotide sequence of Tc100, a gene encoding PTc100, a new Trypanosoma antigen, and the amino acid sequence of PTc100 are described. Tc100 and PTc100, or fragments thereof, modified or otherwise, can be used directly or indirectly for the detection of Trypanosoma cruzi, or for the monitoring of the infection generated by Trypanosoma cruzi, in man or in animals.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: August 23, 2005
    Assignee: Bio Merieux
    Inventors: Glaucia Paranhos-Baccala, Mylene Lesenechal, Michel Jolivet
  • Monoclonal antibodies directed against hepatitis b viruses
    Publication number: 20040219154
    Abstract: The invention concerns a monoclonal antibody capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two and advantageously more than two, mutated forms of the HBsAg antigen, the monoclonal antibody binding with the peptide sequence consisting of at least 6 adjacent amino acids in the 199-208 region of the HBsAg antigen, and advantageously binding with the peptide sequence formed by the 199-208 region of the HbsAg antigen.
    Type: Application
    Filed: September 8, 2003
    Publication date: November 4, 2004
    Inventors: Colette Jolivet-Reynaud, Mylene Lesenechal, Nicole Battail-Poirot, Laurence Becquart
  • Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
    Patent number: 6403103
    Abstract: The nucleotide sequence of Tc100, a gene encoding a new antigenic protein from Trypanosoma cruzi called PTc100, is disclosed. The amino acid sequence of the PTc100 protein is also disclosed, along with the amino acid sequence of the dominant antigenic epitope of the PTc100 protein. The PTc100 protein and Tc100 gene, or a fragment thereof, modified or otherwise, can be used directly or indirectly for the detection of Trypanosoma cruzi, or for the monitoring of an infection generated by T. cruzi in man or animals.
    Type: Grant
    Filed: December 10, 1997
    Date of Patent: June 11, 2002
    Assignee: Bio Merieux
    Inventors: Glaucia Paranhos-Baccala, Mylene Lesenechal, Michel Jolivet, Bernard Mandrand
  • Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease
    Patent number: 6270767
    Abstract: The nucleotide sequence of Tc100, a gene encoding PTc100, a new Trypanosoma antigen, and the amino acid sequence of PTc100 are described. Tc100 and PTc100, or fragments thereof, modified or otherwise, can be used directly or indirectly for the detection of Trypanosoma cruzi, or for the monitoring of the infection generated by Trypanosoma cruzi, in man or in animals.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: August 7, 2001
    Assignee: Bio Merieux
    Inventors: Glaucia Paranhos-Baccala, Mylene Lesenechal, Michel Jolivet
  • Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease
    Patent number: 5820864
    Abstract: The present invention relates to a new Trypanosoma cruzi antigen, called PTc100, and to a code gene ?sic! encoding the latter, called Tc100.According to the invention, the nucleotide sequences of Tc100 and the amino acid sequences of PTc100 were determined and described.PTc100 and Tc100, or fragments thereof, modified or otherwise, can be used directly or indirectly for the detection of Trypanosoma cruzi, or for the monitoring of the infection generated by the latter, in man or in animals.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 13, 1998
    Assignee: Bio Merieux
    Inventors: Glaucia Paranhos-Baccala, Mylene Lesenechal, Michel Jolivet